Table 1 Baseline patient characteristics

From: Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil

N

46

Median age (range)

63 (40–78)

Male, n (%)

31 (67)

Female, n (%)

15 (33)

ECOG PS, n (%)

 

 0

30 (65)

 1

16 (35)

Primary tumour site, n (%)

 

 Colon

38 (83)

 Rectum

8 (17)

Number of organs involved, n (%)

 

 1

26 (57)

 2

18 (39)

3

2 (4)

Site of metastases, n (%)

 

 Liver

27 (59)

 Lung

5 (11)

 Peritoneum/nodes/others

14 (30)

Prior adjuvant chemotherapy, n (%)

13 (28)

Median number of lesions measured per patient (range)

3 (1–7)

Median baseline tumour area (cm2) (range)

21 (1–343)